(Q43797848)

English

Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents.

scientific article published on 16 January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Raphael A Itzykson

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

20

object named as

P Fenaux

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Odile Beyne-Rauzy

4

object named as

O Beyne-Rauzy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

C Kelaidi

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

R Sapena

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

V Coiteux

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

N Vey

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Stamatoullas

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

B Choufi

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

J Delaunay

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

M-P Gourin

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

S Cheze

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

C Ravoet

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Ferrant

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

M Escoffre-Barbe

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

L Aljassem

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

E Raffoux

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

L Adès

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

F Dreyfus

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

16 January 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1283-1290

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

https://scigraph.springernature.com/pub.10.1038/leu.2013.16

0 references

Proposals for the classification of the myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.16

21 January 2018

Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.16

21 January 2018

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.16

21 January 2018

Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.16

21 January 2018

Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.16

21 January 2018

Treatment of myelodysplastic syndromes with 5q deletion before the lenalidomide era; the GFM experience with EPO and thalidomide

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.16

21 January 2018

New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.16

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.16

21 January 2018

A prognostic score for patients with lower risk myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.16

21 January 2018

Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.16

21 January 2018

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.16

21 January 2018

The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.16

21 January 2018

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.16

21 January 2018

Asymptotically Efficient Rank Invariant Test Procedures

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.16

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2013.16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23370672%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43797848&oldid=2103425462"